Alteogen Inc
KOSDAQ:196170

Watchlist Manager
Alteogen Inc Logo
Alteogen Inc
KOSDAQ:196170
Watchlist
Price: 309 000 KRW 4.04%
Market Cap: 16.5T KRW
Have any thoughts about
Alteogen Inc?
Write Note

P/FCFE
Price to FCFE

5 698.4
Current
-35.5
Median
25.2
Industry
Higher than median
Higher than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
5 698.4
=
Market Cap
16T KRW
/
FCFE
2.9B KRW
All Countries
Close
Market Cap P/FCFE
KR
Alteogen Inc
KOSDAQ:196170
16T KRW 5 698.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 203 184.8
US
Abbvie Inc
NYSE:ABBV
320.1B USD 12.8
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 25.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD -91
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 11.4
US
Epizyme Inc
F:EPE
94.1B EUR -428.4
AU
CSL Ltd
ASX:CSL
135.4B AUD 79.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD 25
US
Seagen Inc
F:SGT
39.3B EUR -58.9
NL
argenx SE
XBRU:ARGX
34.5B EUR -109.5

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More